SciTech Chronicles. . . . . . . . .March 18th, 2026
Vol V Issue 64 Who Said this? The greatest obstacle to our understanding of the US Constitution is our familiarity with it. Today, 426 links

seen from Malaysia
seen from Singapore

seen from United States
seen from United States
seen from United States

seen from Russia
seen from South Korea
seen from China
seen from Netherlands

seen from United Kingdom

seen from China
seen from China
seen from Malaysia

seen from Türkiye
seen from United Kingdom
seen from Germany
seen from China
seen from China

seen from Germany
seen from China
SciTech Chronicles. . . . . . . . .March 18th, 2026
Vol V Issue 64 Who Said this? The greatest obstacle to our understanding of the US Constitution is our familiarity with it. Today, 426 links
Health, Blocking enzyme cut cancer spread:In their experiments, they showed that blocking enzyme prevent http://bit.ly/hgwBON
Treating Metastasis of Breast Cancer
Ninety percent of cancer deaths are due to the original tumour migrating to other parts of the body, a process known as metastasis. However, it appears that this process is powered by an enzyme named LOXL2, which helps cancerous tissue to leave breast tissue and enter the bloodstream to travel to other organs.
The researchers at the Institue of Cancer Research have shown LOXL2 to be in high concentrations during early stages of cancer spreading, and patients with higher levels to have lower survival rates.
Because LOXL2 is an enzyme, it can be blocked either naturally or artifically (using targetted drugs). The importance of this enzyme has made targetted drug design a real possibility and has a very realistic chance of success.
Dr Julie Sharp, senior science information manager at Cancer Research UK, said that what the team have shown offers a new approach to tackle the problem of metastases.